Veradigm Inc. (MDRX)

Market Cap	800.35M -0.8%
Revenue (ttm)	594.41M -60.9%
Net Income	-291.54M
EPS	-2.70
Shares Out	170.29M
PE Ratio	n/a
Forward PE	19.96
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,480
Open	4.600
Previous Close	4.800
Day's Range	4.600 - 4.880
52-Week Range	3.250 - 6.000
Beta	0.56
Analysts	Buy
Price Target	6.50 (+38.3%)
Earnings Date	Sep 11, 2026

About Veradigm

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EH...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1986
• Employees: 2,300
• Stock Exchange: OTCMKTS
• Ticker Symbol: MDRX

Analyst Summary

According to 2 analysts, the average rating for MDRX stock is "Buy." The 12-month stock price target is $6.50, which is an increase of 38.30% from the latest price.

Price Target

$6.50

(38.30% upside)

Analyst Consensus: Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 19, 2026

Data Sources Report a data error